Literature DB >> 2116509

Osteoporosis after cranial irradiation for acute lymphoblastic leukemia.

V Gilsanz1, M E Carlson, T F Roe, J A Ortega.   

Abstract

A prospective study was conducted to investigate the possibility of osteoporosis after treatment for childhood acute lymphoblastic leukemia (ALL). Forty-two survivors of ALL had the trabecular bone density of the spine evaluated by quantitative computed tomography, 6 to 98 months (mean 42 months) after completion of chemotherapy. The ALL survivors had significantly lower bone density than age-, gender-, and race-matched nonleukemic control subjects had (10% less, p less than 0.001); this decrease was accounted for solely by the subset of patients who had received cranial irradiation (n = 30; p less than 0.001). The relative reduction in bone density in ALL survivors was unrelated to age at the time of diagnosis or time without therapy. The effects on bone density of 18 Gy and of 22.5 to 25.2 Gy were indistinguishable. We conclude that survivors of ALL commonly have reduced bone density in the lumbar spine and suggest that the diminution is related to nervous system irradiation, not to the disease or to chemotherapy.

Entities:  

Mesh:

Year:  1990        PMID: 2116509     DOI: 10.1016/s0022-3476(05)80536-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  20 in total

1.  Risk factors for osteoporosis in long-term survivors of intracranial germ cell tumors.

Authors:  M J Kang; S M Kim; Y A Lee; C H Shin; S W Yang; J S Lim
Journal:  Osteoporos Int       Date:  2011-11-05       Impact factor: 4.507

2.  Bone density and structure in long-term survivors of pediatric allogeneic hematopoietic stem cell transplantation.

Authors:  Sogol Mostoufi-Moab; Jill P Ginsberg; Nancy Bunin; Babette Zemel; Justine Shults; Mary B Leonard
Journal:  J Bone Miner Res       Date:  2012-04       Impact factor: 6.741

3.  Bone mineral density in survivors of childhood brain tumours.

Authors:  M Petraroli; E D'Alessio; E Ausili; A Barini; P Caradonna; R Riccardi; M Caldarelli; A Rossodivita
Journal:  Childs Nerv Syst       Date:  2006-10-13       Impact factor: 1.475

Review 4.  Mineral accretion in growing bones--a framework for the future?

Authors:  N J Shaw; N J Bishop
Journal:  Arch Dis Child       Date:  1995-02       Impact factor: 3.791

5.  Calcium and cholecalciferol supplementation provides no added benefit to nutritional counseling to improve bone mineral density in survivors of childhood acute lymphoblastic leukemia (ALL).

Authors:  S C Kaste; A Qi; K Smith; H Surprise; E Lovorn; J Boyett; R J Ferry; M V Relling; S A Shurtleff; C H Pui; L Carbone; M M Hudson; K K Ness
Journal:  Pediatr Blood Cancer       Date:  2014-01-07       Impact factor: 3.167

6.  Effect of Low-Magnitude, High-Frequency Mechanical Stimulation on BMD Among Young Childhood Cancer Survivors: A Randomized Clinical Trial.

Authors:  Rona J Mogil; Sue C Kaste; Robert J Ferry; Melissa M Hudson; Daniel A Mulrooney; Carrie R Howell; Robyn E Partin; Deo K Srivastava; Leslie L Robison; Kirsten K Ness
Journal:  JAMA Oncol       Date:  2016-07-01       Impact factor: 31.777

Review 7.  Bone mineral density deficits and fractures in survivors of childhood cancer.

Authors:  Carmen L Wilson; Kirsten K Ness
Journal:  Curr Osteoporos Rep       Date:  2013-12       Impact factor: 5.096

8.  The use of bone age for bone mineral density interpretation in a cohort of pediatric brain tumor patients.

Authors:  E Brannon Morris; John Shelso; Matthew P Smeltzer; Nicole A Thomas; E Jane Karimova; Chin-Shang Li; Thomas Merchant; Amar Gajjar; Sue C Kaste
Journal:  Pediatr Radiol       Date:  2008-09-04

9.  Pediatric Hodgkin lymphoma survivors at negligible risk for significant bone mineral density deficits.

Authors:  Sue C Kaste; Monika L Metzger; Anum Minhas; Zang Xiong; Shesh N Rai; Kirsten K Ness; Melissa M Hudson
Journal:  Pediatr Blood Cancer       Date:  2009-04       Impact factor: 3.167

10.  Bone metabolism and mineralisation after cytotoxic chemotherapy including ifosfamide.

Authors:  J de Schepper; S Hachimi-Idrissi; O Louis; R Maurus; J Otten
Journal:  Arch Dis Child       Date:  1994-10       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.